Loading clinical trials...
Loading clinical trials...
Retrospective Analysis of Prognostic Indicators of Diabetic Foot Ulcer
Conditions
Interventions
Level of blood sugar control (e.g., hemoglobin A1C), severity of infection, blood supply status, and other complications (e.g., peripheral neuropathy)
Locations
1
China
National Clinical Medical Research Center for Metabolic Diseases (Shanghai)
Shanghai, China
Start Date
October 31, 2024
Primary Completion Date
April 30, 2025
Completion Date
October 30, 2025
Last Updated
January 10, 2025
NCT07541196
NCT07224321
NCT01399385
NCT07340320
NCT06513026
NCT07536516
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions